LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.017783
 71.78 27.76 1334 6893 0.1935 0.6270
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 71.78 27.76 1347 6893 0.1954 0.6290
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 71.78 27.76 182 6893 0.0264 0.2666
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 71.78 27.76 1711 6893 0.2482 0.6787
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 73.48 27.76 1279 6957 0.1838 0.6171
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 73.48 27.76 1290 6957 0.1854 0.6188
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 73.48 27.76 200 6957 0.0287 0.2812
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 73.48 27.76 1810 6957 0.2601 0.6891
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 75.19 27.76 1399 7015 0.1994 0.6342
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 75.19 27.76 1411 7015 0.2011 0.6359
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 75.19 27.76 192 7015 0.0274 0.2742
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 75.19 27.76 1749 7015 0.2493 0.6805
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 76.89 27.76 1357 7025 0.1932 0.6277
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 76.89 27.76 1367 7025 0.1946 0.6292
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 76.89 27.76 181 7025 0.0258 0.2647
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 76.89 27.76 1839 7025 0.2618 0.6909
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 78.60 27.76 1412 7045 0.2004 0.6354
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 78.60 27.76 1421 7045 0.2017 0.6367
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 78.60 27.76 196 7045 0.0278 0.2772
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 78.60 27.76 1899 7045 0.2695 0.6973
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 80.31 27.76 1443 6976 0.2069 0.6414
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 80.31 27.76 1454 6976 0.2084 0.6429
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 80.31 27.76 206 6976 0.0295 0.2858
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 80.31 27.76 1854 6976 0.2658 0.6938
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 82.01 27.76 1509 7000 0.2156 0.6501
MN20160318_Q01
D08